Melatonin and angiogenesis potential in stem cells

Area of Science:

• Regenerative Medicine
• Cardiovascular Research
• Molecular Biology

Background:

• Ischemic heart diseases, including myocardial infarction, are leading causes of death, often leading to chronic heart failure despite interventions.
• Angiogenesis, the formation of new blood vessels, is crucial for restoring blood perfusion to ischemic tissues and preventing disease progression.
• Stem cells offer therapeutic potential through differentiation or paracrine signaling, but their angiogenic regulation needs further understanding.

Purpose of the Study:

• To evaluate the current data on how melatonin (mel) influences the angiogenic properties of stem cells.
• To explore the potential of melatonin as an adjunct therapy in regenerative medicine for ischemic conditions.

Main Methods:

• Systematic review and evaluation of existing scientific literature.
• Analysis of studies investigating the effects of melatonin on stem cell-mediated angiogenesis.

Main Results:

• Melatonin exhibits pleiotropic actions, including antioxidant, anti-inflammatory, and potentially pro-angiogenic effects.
• Evidence suggests melatonin may modulate stem cell behavior to promote angiogenesis, although mechanisms are under investigation.
• The review consolidates findings on melatonin's role in stem cell-based therapies for ischemia.

Conclusions:

• Melatonin shows promise in enhancing stem cell-driven angiogenesis for treating ischemic diseases.
• Further research into melatonin's mechanisms of action on stem cells could lead to novel therapeutic strategies for heart failure and other ischemic pathologies.